Products
Latest News
FAQ
Log in
|
Search
Search
Filters
Clear All
Study Phase
Early Phase 1
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
Phase 4
Not Applicable
Recruitment Status
Recruiting
Not yet recruiting
Active, not recruiting
Completed
Suspended
Terminated
Withdrawn
Study Type
Interventional
Observational
Expanded Access
Others
Eligibility Sex
All
Female
Male
Healthy Volunteers
All
Include
Exclude
Found
1
clinical trials
|
View Analysis
Sort by:
Newest First
Effect of Tirzepatide Plus Intensive Lifestyle Therapy on Body Weight and Metabolic Health in Latinos With Obesity
Phase 4
Terminated
Conditions
Obesity
Metabolic Disease
Interventions
Behavioral: Standard Care
Behavioral: Culturally-tailored dietary and behavioral intensive lifestyle intervention
Drug: Placebo
Drug: Tirzepatide
Subscribe
First Posted Date
2023-08-24
Last Posted Date
2024-07-29
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
32
Registration Number
NCT06009653
Locations
🇺🇸
Sansum Diabetes Research Institute, Santa Barbara, California, United States
Subscribe
Prev
1
Next
© Copyright 2025. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy